abstract |
The present invention relates to a method of treating a disease, disorder, or condition in a patient comprising administering to the patient a therapeutically effective amount of a thiazole derivative, tetomilast. The invention further relates to administering at least one β 2 -adrenergic receptor agonist with tetomilast to treat a disease, disorder, or condition. The invention further relates to administering an anti-inflammatory steroid with tetomilast and at least one β 2 -adrenergic receptor agonist to treat a disease, disorder, or condition. |